Application of five biomarkers in preparation or screening of liver cancer diagnostic reagent
A biomarker, cancer diagnosis technology, applied in the field of five biomarkers in the preparation or screening of diagnostic reagents for liver cancer, can solve problems such as tumor recurrence, and achieve the effect of predicting the risk of cancer recurrence
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0118] The kit contains:
[0119] Trizol lysate (Invitrogen, 15596-026);
[0120] RNAse-free homogenizer;
[0121] RNAse-free 1.5ml tube;
[0122] Chloroform;
[0123] isopropanol;
[0124] Washing solution (75% V / V ethanol prepared with RNAse-free water);
[0125] RNAse-free water;
[0126] Reverse transcription reagent mixture (10 μL / tube, TAKARA, RR047A);
[0127] Q-PCR reagent mix (TAKARA, 639676);
[0128] Primer diluent (aqueous solution containing primers).
[0129] The operation steps are as follows:
[0130] 1. Tumor sample preparation: For patients with multiple liver cancer foci, a piece of tumor (50 mg / part) was taken from each foci, and a total of 3 foci were taken; for patients with less than 3 liver cancer foci, random Take 3 tumor blocks (50 mg / part); the tumor tissues are labeled as HCC1, HCC2, HCC3. Take 3 pieces of paracancerous tissues randomly (50 mg / part), and mark Nor1, Nor2, Nor3.
[0131] 2. Cut the tissue as small as possible with sterilize...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com